New strength of Glucophage SR

Merck Serono has a new 1000mg strength of its prolonged-release metformin preparation, Glucophage SR, indicated in the management of type II diabetes either as monotherapy or as adjunct to other therapies.

The 1000mg tablets will reduce the tablet burden on patients prescribed a high dose of metformin SR, allowing for easier administration.

The 1000mg tablets are intended for patients who have already been treated with metformin sustained-release or immediate-release preparations.

View Glucophage SR drug record

Further information: Merck Serono

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases